| Name | Title | Contact Details |
|---|
John T. Mather Memorial Hospital is a Port Jefferson, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Woodlawn Hospital is a Rochester, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Jackson Health System, an integrated healthcare delivery system, consists of its centerpiece, Jackson Memorial Hospital; multiple primary care and specialty care centers; a variety of school-based clinics serving many elementary, middle and high schools; two long-term care nursing facilities; six Corrections Health Services clinics; a network of mental health facilities; Holtz Children`s Hospital, Jackson Rehabilitation Hospital, Jackson Behavioral Health Hospital, Jackson North Medical Center and Jackson South Medical Center. JHS is also home to the Ryder Trauma Center, Miami-Dade County`s only Level 1 adult and pediatric trauma center; and the UM/JM Burn Center, one of the leading burn treatment centers in the nation and the only one in South Florida. Working in affiliation with the University of Miami Leonard M. Miller School of Medicine, Florida International University Herbert Wertheim College of Medicine and others, Jackson provides a wide range of patient services, educational programs, a clinical setting for research activities and a number of health-related community services.
We seek to provide emotional and spiritual nurture, always being sensitive to the traditions and beliefs of those we serve, and ensuring ongoing access to the clergy of all our patients. We collaborate with physicians and staff in the hospital because
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.